In this episode of The Good GP, host Dr Sean Stevens speaks with Professor Nick Zwar, Chair of the RACGP Travel Medicine Specific Interest Group, to discuss the state of travel medicine in Australia post-COVID-19 pandemic.

Professor Zwar outlines how the pandemic led to a sudden halt in international travel and impacted travel medicine practice. Many have adapted by shifting their focus back to general practice, advising patients stranded overseas, and planning for a resumption of travel. He also notes the practical implications, such as unused vaccine stock and the adoption of telehealth.

Also discussing the resumption of international travel, with Australians returning to pre-pandemic travel levels, including higher-risk activities like cruise ship travel. They observe that despite the risks of infectious diseases, most patients are eager to travel and may not be as concerned about COVID-19 as practitioners might expect.

Looking ahead, Professor Zwar identifies several challenges in travel medicine. These include changing patterns of infectious diseases (notably respiratory infections, dengue fever, Japanese encephalitis, and measles), emerging threats like monkeypox (Mpox), and the increasing prevalence of antimicrobial resistance affecting management of traveler's diarrhoea. He also highlights the complexity of advising immunocompromised travellers, particularly those on biological therapies.

The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network

If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our instagram page: @thegoodgppodcast. Follow us for more updates!